EDGAR Filing Documents for 0001493152-21-020181

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001493152-21-020181

Filing Date

2021-08-16

Accepted

2021-08-16 16:21:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		forms-3.htm	S-3	306386
2		ex5-1.htm	EX-5.1	13190
3		ex23-1.htm	EX-23.1	5498
4		ex23-2.htm	EX-23.2	4049
5		ex5-1_001.jpg	GRAPHIC	5806
6		ex5-1_002.jpg	GRAPHIC	2905
7		ex23-1_001.jpg	GRAPHIC	3828
	Complete submission text file	0001493152-21-020181.txt		347830

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019

Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760

Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)